Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00169039 · ClinicalTrials.gov registry record · Phase 4
Clozapine Versus Chlorpromazine for Treatment-Unresponsive Schizophrenia
A Phase 4 study, sponsored by Harvard Medical School (HMS and HSDM).
- Terminated
- Registry status
- Phase 4
- Development phase
- 66
- Enrollment target
NCT00169039 is a Phase 4 study that was terminated before completion, run by Harvard Medical School (HMS and HSDM). The registered enrollment target is 66 participants.
The verdict
NCT00169039, a Phase 4 study, was terminated before completion, sponsored by Harvard Medical School (HMS and HSDM).
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 66 participants
- Enrollment target
Study Summary
This study will examine the physical response to clozapine or chlorpromazine in people with schizophrenia that has not improved with treatment.
Interventions
- DRUG Chlorpromazine
- DRUG Clozapine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 1994-12 |
| Est. Completion | 2002-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00169039
The ClinicalTrials.gov registry entry for NCT00169039 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Harvard Medical School (HMS and HSDM), which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Chlorpromazine is the first listed.
NCT00169039 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00169039 about?
NCT00169039 is a clinical study titled "Clozapine Versus Chlorpromazine for Treatment-Unresponsive Schizophrenia". This study will examine the physical response to clozapine or chlorpromazine in people with schizophrenia that has not improved with treatment.
What is the current status of trial NCT00169039?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 66 participants. The study started on 1994-12. Estimated completion is 2002-02.
What interventions are being tested in trial NCT00169039?
The interventions under investigation include: Chlorpromazine (DRUG), Clozapine (DRUG).
Who is sponsoring clinical trial NCT00169039?
This trial is sponsored by Harvard Medical School (HMS and HSDM), which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.